At SusHi Tech Tokyo 2024, our CEO Jan Hendriks provided an insightful presentation on our patented MTC-Y transdermal drug delivery technology and showcases our main 2 projects – Transdermal Insulin and Transdermal Semaglutide.

See Jan’s engaging presentation for yourself: